A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries
Background: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwide; low- and middle-income countries (LMICs) are disproportionately affected. Economic evaluations are a useful decision tool to assess costs versus benefits of hepatitis B virus (HBV) screening. No pu...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
BioMed Central Ltd
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/67216 |